Log in

Chemours Stock Price, Forecast & Analysis (NYSE:CC)

$16.98
-1.45 (-7.87 %)
(As of 11/19/2019 09:07 AM ET)
Today's Range
$16.71
Now: $16.98
$18.42
50-Day Range
$13.13
MA: $16.23
$19.80
52-Week Range
$11.71
Now: $16.98
$41.60
Volume3.21 million shs
Average Volume2.59 million shs
Market Capitalization$2.78 billion
P/E Ratio2.99
Dividend Yield5.43%
Beta2.57
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
Phone302-773-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.64 billion
Cash Flow$7.16 per share
Book Value$5.96 per share

Profitability

Net Income$995 million

Miscellaneous

Employees7,000
Market Cap$2.78 billion
Next Earnings Date2/13/2020 (Estimated)
OptionableOptionable

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Chemours (NYSE:CC) Frequently Asked Questions

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Wednesday, October 30th. Investors of record on Friday, November 15th will be paid a dividend of $0.25 per share on Monday, December 16th. This represents a $1.00 annualized dividend and a dividend yield of 5.89%. The ex-dividend date is Thursday, November 14th. View Chemours' Dividend History.

How will Chemours' stock buyback program work?

Chemours announced that its Board of Directors has initiated a stock repurchase program on Monday, December 4th 2017, which permits the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company's management believes its shares are undervalued.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) announced its earnings results on Monday, November, 4th. The specialty chemicals company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.56 by $0.03. The specialty chemicals company earned $1.39 billion during the quarter, compared to analyst estimates of $1.40 billion. Chemours had a net margin of 7.24% and a return on equity of 58.38%. The company's revenue for the quarter was down 14.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.49 EPS. View Chemours' Earnings History.

When is Chemours' next earnings date?

Chemours is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Chemours.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY19 earnings guidance on Monday, November, 4th. The company provided earnings per share guidance of $2.37-3.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.47.

What price target have analysts set for CC?

13 Wall Street analysts have issued 12-month price objectives for Chemours' stock. Their forecasts range from $14.50 to $52.00. On average, they anticipate Chemours' stock price to reach $27.14 in the next twelve months. This suggests a possible upside of 59.8% from the stock's current price. View Analyst Price Targets for Chemours.

What is the consensus analysts' recommendation for Chemours?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Chemours.

Has Chemours been receiving favorable news coverage?

News coverage about CC stock has been trending very negative this week, InfoTrie reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Chemours earned a news sentiment score of -3.9 on InfoTrie's scale. They also assigned press coverage about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Chemours.

Are investors shorting Chemours?

Chemours saw a increase in short interest during the month of October. As of October 15th, there was short interest totalling 13,710,000 shares, an increase of 9.2% from the September 15th total of 12,560,000 shares. Based on an average daily trading volume, of 3,460,000 shares, the days-to-cover ratio is currently 4.0 days. Currently, 8.5% of the shares of the company are sold short. View Chemours' Current Options Chain.

Who are some of Chemours' key competitors?

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), Micron Technology (MU), NVIDIA (NVDA), Alibaba Group (BABA), DowDuPont (DWDP), AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Intel (INTC) and Pfizer (PFE).

Who are Chemours' key executives?

Chemours' management team includes the folowing people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include DNB Asset Management AS (0.39%), Retirement Systems of Alabama (0.36%), Selz Capital LLC (0.34%), Alberta Investment Management Corp (0.30%), Rhumbline Advisers (0.26%) and California Public Employees Retirement System (0.21%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.

Which institutional investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including Teacher Retirement System of Texas, Gateway Investment Advisers LLC, Selz Capital LLC, Great West Life Assurance Co. Can, Zurcher Kantonalbank Zurich Cantonalbank, Nisa Investment Advisors LLC, Brookstone Capital Management and Dupont Capital Management Corp. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.

Which institutional investors are buying Chemours stock?

CC stock was acquired by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Traynor Capital Management Inc., WBI Investments Inc., State of New Jersey Common Pension Fund D, DNB Asset Management AS, Railway Pension Investments Ltd, Investors Research Corp and Pacer Advisors Inc.. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $16.98.

How big of a company is Chemours?

Chemours has a market capitalization of $2.78 billion and generates $6.64 billion in revenue each year. The specialty chemicals company earns $995 million in net income (profit) each year or $5.67 on an earnings per share basis. Chemours employs 7,000 workers across the globe.View Additional Information About Chemours.

What is Chemours' official website?

The official website for Chemours is http://www.chemours.com/.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for Chemours (NYSE CC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  476 (Vote Outperform)
Underperform Votes:  531 (Vote Underperform)
Total Votes:  1,007
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel